Concepedia

John L. Hays

JL

Statistics

Publications

41

Citations

1.8K

H-Index

24

Active since

2003

Affiliations

The Ohio State University(Current)

The Ohio State University Wexner Medical Center

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

National Cancer Institute

Center for Cancer Research

John L. Hays is an author at The Ohio State University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2003–2024

41

Publications

41

Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses

Jung Min Lee, John L. Hays, Christina M. Annunziata et al. · JNCI Journal of the National Cancer Institute · 2014 · 183 citations · Full text

, , +14

Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma

Melanie A. Krook, Alexandria Lenyo, Max Wilberding et al. · Molecular Cancer Therapeutics · 2020 · 138 citations · Full text

, , +17

Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target

U. Saini, Srikanth I. Naidu, Adam C. ElNaggar et al. · Oncogene · 2016 · 115 citations

, , +17

A Microfluidic Chip Enables Isolation of Exosomes and Establishment of Their Protein Profiles and Associated Signaling Pathways in Ovarian Cancer

Kalpana Deepa Priya Dorayappan, Miranda L. Gardner, Colin L. Hisey et al. · Cancer Research · 2019 · 111 citations · Full text

, , +17

Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398

Jharna Datta, Senthilkumar Damodaran, Hannah Parks et al. · Molecular Cancer Therapeutics · 2017 · 93 citations · Full text

, , +17

1–5 of 41